We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




C-reactive Protein Predicts ICU Infection

By HospiMedica staff writers
Posted on 28 Apr 2006
Daily monitoring of C-reactive protein (CRP) levels can help predict infections acquired in the intensive care unit (ICU), according to a new study published in the April 24 issue of Critical Care, a publication of BioMed Central.

Researchers analyzed the CRP levels of patients admitted to the ICU during 72 hours or more. More...
Among the patients selected for the study, 35 acquired an infection during their stay in the ICU and 28 did not. Patient records of CRP levels were measured during the five days before diagnosis of infection or ICU discharge.

The researchers found that a daily variation of CRP levels greater than 4.1 mg/dl is a good marker for prediction of infection, with 92.1% sensitivity and 71.4% specificity. When combined with a CRP concentration greater than 8.7 mg/dl, the prediction power increased further: 88% of patients with CRP variations greater than 4.1 and a CRP concentration greater than 8.7 mg/dl developed an infection. The researchers concluded that monitoring CRP progression can aid clinical decision-making and the prescription of antibiotics in ICUs.

The study was conducted by Dr. Pedro Povoa, of the San Francisco Xavier Hospital in Lisbon (Portugal) and colleagues from the Garcia de Orta Hospital in Almada (also in Portugal).

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.